Wilson James Ninsider trades
In SEC Form 4 filings, Wilson James N is listed as Director of Corcept Therapeutics Inc (CORT). In the last 90 days, Wilson James N sold $2.26M of Corcept Therapeutics Inc (CORT) on the open market and bought none. All 6 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CORTCorcept Therapeutics Inc | Director | 6 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Inc | Oct 15 | Oct 16 | S | 6,654 | $114.48 | Sale −$761,717 | 1,057,889 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 15 | Oct 16 | S | 3,046 | $115.39 | Sale −$351,476 | 1,054,843 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 15 | Oct 16 | S | 300 | $116.30 | Sale −$34,889 | 1,054,543 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 15 | Sep 16 | S | 6,800 | $110.27 | Sale −$749,835 | 1,067,743 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 15 | Sep 16 | S | 400 | $110.84 | Sale −$44,335 | 1,067,343 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 15 | Sep 16 | S | 2,800 | $111.70 | Sale −$312,771 | 1,064,543 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.